Missoula-based Inimmune Corporation was named the Montana Ambassadors Business of the Year in an announcement this week by Governor Gianforte. This award is presented annually to a Montana business that “has demonstrated extraordinary innovation and success in their field of business (www.montanaambassadors.com).”
Inimmune, www.inimmune.com, is emblematic of the type of startup success story that is transforming Montana’s economy (https://www.youtube.com/watch?v=YN2mKo5-n7g). The company has partnered with the University of Montana to advance basic research discoveries into medicines and train a new workforce for Montana’s growing biotech sector.
In 2020, Inimmune secured one of the largest Series A investment rounds in Montana history with a $22 million commitment from Two Bear Capital, www.twobearcapital.com (Whitefish, MT). When the Series A investment was announced last July, Dr. Jay Evans, Inimmune’s CEO, noted that the company “could have looked outside of Montana for investors but were happy to find a local VC firm (Two Bear Capital) that connected with our vision to grow a world-class biotech company right here in Montana.” (The Rise of Venture Capital in Montana, Flathead Beacon, Feb 24, 2021).
Founded in 2016, Inimmune develops vaccines and immunotherapeutics in areas of high unmet medical need to communities across Montana and the country. Inimmune is advancing treatments for allergy, oncology, autoimmunity, infectious disease, and opioid addiction with several lead candidates moving to Phase I human clinical trials in 2022. “Being located in Montana is a key to our success,” said Dr. Evans, “Many of our employees are graduates of Montana colleges or have a strong connection to the community. This strong sense of community and desire to help others keeps our team focused on innovation and developing the next generation of immunotherapeutics.”
For more information, press only:
See the full list of award recipients here.